top of page

Email:  bd@sidmexinovia.com | Phone:  +918866862020

  • Whatsapp
  • Instagram
  • Facebook
  • X
  • LinkedIn

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Mounjaro 2.5mg Injection

Mounjaro 2.5mg Injection

Manufacturer/Marketed By : ELI LILLY AND COMPANY INDIA PVT LTD

$139.76 $30.40

Mounjaro 2.5mg Injection, an innovative medication, contains Tirzepatide as its active ingredient. It belongs to the pharmacological class of GLP-1 and GIP receptor agonists, representing a first-in-class dual-incretin therapy. This...

Collapsible text is perfect for longer content like paragraphs and descriptions. It's a great way to give people more information while keeping your layout clean. Link your text to anything, including an external website or a different page. You can set your text box to expand and collapse when people click, so they can read more or less info.

TIRZEPATIDE

Active Pharmaceutical Ingredient

Mounjaro 2.5mg Injection

SKU ELI LILLY AND COMPANY INDIA PVT LTD
原始價格

139,76$

促銷價格

30,40$

Mounjaro 2.5mg Injection, an innovative medication, contains Tirzepatide as its active ingredient. It belongs to the pharmacological class of GLP-1 and GIP receptor agonists, representing a first-in-class dual-incretin therapy. This Mounjaro 2.5mg solution for injection is primarily used to manage blood sugar levels in adults with type 2 diabetes mellitus who are unable to achieve adequate glycemic control through oral antidiabetic medications, diet, and exercise. Mounjaro 2.5mg for type 2 diabetes has become a preferred choice for many patients due to its effectiveness in controlling glucose levels. By mimicking the action of two natural incretin hormones GLP-1 and GIP. Mounjaro 2.5mg injection enhances glucose-dependent insulin secretion, suppresses glucagon release, slows gastric emptying, and reduces appetite. These mechanisms help lower post-meal blood sugar levels and improve overall metabolic control. Administered once weekly via subcutaneous injection, whether as a Mounjaro 2.5mg pen or Mounjaro 2.5mg vial, it offers convenience and long-term benefits for diabetes management. Guidance on Mounjaro 2.5mg how to inject should always be followed to ensure safe administration. While Mounjaro 2.5mg for weight loss has shown potential in clinical trials, it is not approved for weight loss or the treatment of obesity without a valid prescription and proper medical evaluation. Its off-label use for weight management, including Mounjaro 2.5mg uses for weight loss, should only occur under the supervision of a healthcare professional. Caution is advised in individuals with a history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, or severe gastrointestinal disorders. Patients interested in buy Mounjaro 2.5mg online India or checking the Mounjaro 2.5mg price in India should consult a licensed pharmacy or healthcare provider. For guidance on dosing, the Mounjaro 2.5mg dosage schedule should be strictly followed. Many users also refer to Mounjaro 2.5mg review India to understand real-world experiences and outcomes. For those looking to obtain it locally, information on where to buy Mounjaro 2.5mg pen India is available from authorized distributors.

Active Pharmaceutical Ingredient

TIRZEPATIDE

Uses

• Used along with diet and exercise to improve glycemic control in type 2 diabetes.
• Sometimes used off-label for weight management under medical supervision, but not officially approved for this purpose.

Benefits

Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.

Side Effects

Mounjaro 2.5mg side effects are

Most Common Side Effects

• Pancreatitis
• Thyroid tumors
• Severe hypoglycemia (especially with insulin use)
• Kidney issues due to dehydration

Common Side Effects

• Nausea
• Vomiting
• Diarrhea
• Constipation
• Loss of appetite

How To Use

Inject subcutaneously once a week into the abdomen, thigh, or upper arm. The initial dose is 2.5 mg weekly, which may be increased to 5 mg after 4 weeks, and then gradually titrated up to 15 mg depending on tolerance and blood sugar response. Always rotate injection sites to avoid skin irritation.

Safety Advice

• Breast Feeding: It is unknown whether Mounjaro 2.5mg Injection passes into breast milk. Breastfeeding mothers should seek medical advice.
• Pregnancy: Animal studies indicate potential harm to the fetus. Use during pregnancy only if clearly necessary.
• Lungs: No significant respiratory effects have been reported. Safe for individuals without lung complications.
• Liver: Use with caution in patients with liver impairment. Regular monitoring of liver enzymes is advisable.
• Alcohol: Consuming alcohol may increase the risk of hypoglycemia. Limit alcohol intake while using this medication.
• Driving: Dizziness or hypoglycemia may affect alertness. Exercise caution when operating machinery.

Disclaimer

Sidmex Inovia strives to provide accurate and reliable information; however, all content on this website, including product descriptions and compositions, is for informational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment.

Users are advised to consult a qualified healthcare professional before making any medical decisions. The information provided should not be used for self-diagnosis or self-medication.

All products listed are intended strictly for B2B and bulk inquiry purposes only. Sidmex Inovia does not promote direct consumer use and aims to support, not replace, the healthcare professional–patient relationship.

Product names, trademarks, and brands belong to their respective owners, and their use does not imply any affiliation or endorsement. Sidmex Inovia shall not be held responsible for any consequences arising from the use of the information provided on this website.

bottom of page